Imiquimod cream to prevent basal cell carcinoma in veterans
Part of Cancer, Skin clinical trials.
This study tests whether applying imiquimod cream (a common skin treatment) to the face can prevent new basal cell carcinomas from forming in people who have already had several. It is designed for Veterans at high risk for this type of skin cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a U.S. military Veteran.
- You have had at least two basal cell carcinoma (BCC) skin cancers in the last 5 years, with at least one on your face, neck, ears, or scalp.
- You have not had radiation therapy to your face.
- You have not used imiquimod cream on your face in the past year.
- You have not recently taken certain immune-suppressing or chemotherapy drugs (like checkpoint inhibitors, hedgehog inhibitors, or capecitabine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well the immunotherapy medicine nivolumab works—either by itself or combined with other immune-boosting drugs—for people with advanced basal cell carcinoma that can’t be removed by surgery or has spread. It’s also looking at what to do if the cancer grows again after an earlier immunotherapy.
This trial tests if giving a combination of two immunotherapy drugs (nivolumab and relatlimab) before surgery works better than one drug alone for people with large or high-risk basal cell skin cancer that needs surgery. The goal is to shrink the cancer and make surgery easier.
This trial tests a new drug (SP-002) combined with vismodegib for people with locally advanced basal cell carcinoma, a type of skin cancer that can't be treated with surgery or has come back after surgery. The goal is to see if this combination is safe and effective.
This study tests whether 5-fluorouracil and calcipotriene (medicines used on the skin) can treat certain small, early skin cancers or pre-cancers without surgery. It’s for specific types and locations of lesions and aims to see how well the treatment works and how safe it is.
This trial tests combining a skin cream (imiquimod), a laser treatment, and an immunotherapy drug (cemiplimab) before surgery for high-risk basal cell carcinoma. The goal is to see if this combination shrinks tumors enough to make surgery less disfiguring or damaging to nearby functions.
This early-stage study tests whether a cancer-killing cream (imiquimod) combined with targeted local radiation can shrink and control mycosis fungoides skin lesions. It may help people whose skin lymphoma has not responded to at least one prior standard treatment.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.